Skip to main content

Correction to: Impact of a combined multimodal-aerobic and multimodal intervention compared to standard aerobic treatment in breast cancer survivors with chronic cancer-related fatigue - results of a three-armed pragmatic trial in a comprehensive cohort design

The Original Article was published on 02 March 2017

Correction to: BMC Cancer 17, 166 (2017)

https://doi.org/10.1186/s12885-017-3142-7

Following publication of the original article [1], the authors reported the following errors:

1) In Fig. 3 the y-axis is incorrectly labeled as ‘Mean (SD)’ instead of ‘Mean (standard error)’, since Fig. 3 in fact shows estimates of mean and standard error of the mean. Figure 3 has been corrected in this correction article. The authors have taken the opportunity to include an editing change by denoting the combination therapy arm as ‘CT’ instead of ‘KT’.

Fig. 3
figure1

Presentation of the combined outcome (PC-score) of fatigue (CFS-D)/sleep quality (PSQI) at baseline (T0), after 10 weeks intervention (T1) and 6 months later (T2). High values show high fatigue burden and sleep disturbances. The colored asterisk indicates significantly reduced fatigue/sleep disturbances. Red solid line: AT; blue dashed-dotted line: MT; purple dashed line: CT. Higher PC-scores refer to worse complaints

2) There are some discrepancies in the first paragraph of the ‘Study-group characteristics’ section caused by a mix-up of ITT analyses with analyses based on the full set of initially included patients. In fact, the mean age values range from 56.6 to 60.3 instead of 56.4 to 58.8 years (as correctly shown in Table 2); and the p-values indicating significant group differences of height, rehabilitation, and other disorders are 0.0325, 0.0312, and 0.0369 instead of 0.0168, 0.027, and 0.0313, respectively. None of these changes impair the study outcome or its interpretation in any way.

Reference

  1. 1.

    Kröz M, Reif M, Glinz A, et al. Impact of a combined multimodal-aerobic and multimodal intervention compared to standard aerobic treatment in breast cancer survivors with chronic cancer-related fatigue - results of a three-armed pragmatic trial in a comprehensive cohort design. BMC Cancer. 2017;17:166. https://doi.org/10.1186/s12885-017-3142-7.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Affiliations

Authors

Consortia

Corresponding author

Correspondence to Matthias Kröz.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Kröz, M., Reif, M., Glinz, A. et al. Correction to: Impact of a combined multimodal-aerobic and multimodal intervention compared to standard aerobic treatment in breast cancer survivors with chronic cancer-related fatigue - results of a three-armed pragmatic trial in a comprehensive cohort design. BMC Cancer 20, 1174 (2020). https://doi.org/10.1186/s12885-020-07679-3

Download citation